These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6189106)

  • 1. Plasma estradiol, free testosterone, sex hormone binding globulin binding capacity, and prolactin in benign prostatic hyperplasia and prostatic cancer.
    Rannikko S; Adlercreutz H
    Prostate; 1983; 4(3):223-9. PubMed ID: 6189106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone blood levels and their inter-relationships in normal men and men with benign prostatic hyperplasia (BPH).
    Bartsch W; Becker H; Pinkenburg FA; Krieg M
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):727-36. PubMed ID: 86267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hormone levels among patients with prostatic carcinoma or benign prostatic hyperplasia and clinic controls.
    Hulka BS; Hammond JE; DiFerdinando G; Mickey DD; Fried FA; Checkoway H; Stumpf WE; Beckman WC; Clark TD
    Prostate; 1987; 11(2):171-82. PubMed ID: 2444956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders.
    Grzesiak K; Rył A; Baranowska-Bosiacka I; Rotter I; Dołęgowska B; Słojewski M; Sipak-Szmigiel O; Ratajczak W; Lubkowska A; Metryka E; Piasecka M; Laszczyńska M
    Clin Interv Aging; 2018; 13():1375-1382. PubMed ID: 30122909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endocrine environment of benign prostatic hyperplasia--relationships of sex steroid hormone levels with age and the size of the prostate].
    Suzuki K; Inaba S; Takeuchi H; Takezawa Y; Fukabori Y; Suzuki T; Imai K; Yamanaka H; Honma S
    Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):664-71. PubMed ID: 1379658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
    Cochran RC; Ewing LL; Niswender GD
    Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sex steroids, gonadotrophins and sex hormone-binding globulin in prostatic hyperplasia.
    Ansari MA; Begum D; Islam F
    Ann Saudi Med; 2008; 28(3):174-8. PubMed ID: 18500180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome.
    Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M
    Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of sex hormone levels and risk of prostate cancer.
    Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
    J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia.
    Tan MO; Karabiyik I; Uygur MC; Diker Y; Erol D
    Int Urol Nephrol; 2003; 35(3):357-63. PubMed ID: 15160539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.
    Kristal AR; Schenk JM; Song Y; Arnold KB; Neuhouser ML; Goodman PJ; Lin DW; Stanczyk FZ; Thompson IM
    Am J Epidemiol; 2008 Dec; 168(12):1416-24. PubMed ID: 18945688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
    Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
    J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer.
    Grosman H; Fabre B; Mesch V; Lopez MA; Schreier L; Mazza O; Berg G
    Aging Male; 2010 Jun; 13(2):87-92. PubMed ID: 19921964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine patterns in patients with benign and malignant prostatic diseases.
    Schatzl G; Reiter WJ; Thürridl T; Waldmüller J; Roden M; Söregi S; Madersbacher S
    Prostate; 2000 Aug; 44(3):219-24. PubMed ID: 10906738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration.
    Suzuki K; Ito K; Ichinose Y; Kurokawa K; Suzuki T; Imai K; Yamanaka H; Honma S
    Scand J Urol Nephrol; 1995 Mar; 29(1):65-8. PubMed ID: 7542400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.
    Bartsch W; Horst HJ; Becker H; Nehse G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):650-64. PubMed ID: 325982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of prolactin and androgens in patients with prostatic diseases.
    Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
    Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
    Mantzoros CS; Tzonou A; Signorello LB; Stampfer M; Trichopoulos D; Adami HO
    Br J Cancer; 1997; 76(9):1115-8. PubMed ID: 9365156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.